NCT00341939
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +37 more
- Locations
-
- National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Lymphoma, T-Cell, Cutaneous
Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.
389 public trials
42 recruiting studies
Lymphoma, T-Cell, Cutaneous trial results
NCT02836886
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Columbia University Medical Center New York, United States
NCT01728805
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alabama - Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Gilbert, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
NCT01226472
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Stanford University Stanford, California, United States
NCT01588015
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT02168140
- Conditions
- Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
- Abramson Cancer Center Philadelphia, Pennsylvania, United States
NCT05137847
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Eisai Trial Site 3 Nagoya, Japan
- Eisai Trial Site 1 Osaka, Japan
- Eisai Trial Site 2 Tokyo, Japan
Completed
Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies
NCT01523223
- Conditions
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), +82 more
- Locations
-
- Stanford University Stanford, California, United States
NCT00047060
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00577798
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiac Toxicity, +55 more
- Locations
-
- University of Nebraska Medical Center, Eppley Cancer Center Omaha, Nebraska, United States